Share Talk Ltd

Zak Mir talks to Jason Drummond, CEO of Medpal (AIM: MPAL), as the AI-native digital health and pharmacy group provided a trading update for July 2026, the first month in which the Group's three revenue streams (NHS prescriptions, private prescriptions and SaaS software subscriptions) have all been in operation.Medpal has moved from zero dispensing revenue in October 2025 to an annualised run rate of approximately £8.6 million, based on July 2026 performance. That growth has been achieved in just nine months, with all three revenue streams now operating together: NHS prescriptions, private prescriptions and SaaS software subscriptions.The opportunity is substantial, but the strategy is not simply about selling weight-loss medication. It is about building the underlying health operating system that connects prescribing, automated dispensing, delivery, medicine administration and AI-led patient support.From Zero to £8.6 Million Run RateOur dispensing operations began from a standing start in October 2025. By 1